ExodusPoint Capital Management, LP

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1736225 NEW YORK, NY

Position in XENE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$10,084,663

+$8,675,563 QoQ

Shares Held

173,425

+312.9% QoQ

Ownership

0.179%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. XENE ranks #8 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	178,779	$33,798,169
2	INSM	INSMED Inc	148,133	$24,222,708
3	IONS	Ionis Pharmaceuticals Inc	227,084	$17,051,737
4	ABVX	Abivax S.A.	140,262	$15,618,173
5	COGT	Cogent Biosciences, Inc.	372,175	$14,325,015
6	VERA	Vera Therapeutics, Inc.	317,351	$12,767,030
7	BHVN	Biohaven Ltd.	1,501,099	$12,699,297
8	XENE	Xenon Pharmaceuticals Inc. This page	173,425	$10,084,663

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,084,663	173,425	+312.9%	Shares	Sole	2026-05-14
2025-03-31	$1,409,100	42,000	-39.0%	Shares	Sole	2025-05-14
2024-12-31	$2,700,252	68,884	-73.8%	Shares	Sole	2025-02-12
2024-09-30	$10,339,782	262,631	-26.5%	Shares	Sole	2024-11-12
2024-06-30	$13,926,370	357,178	+131.9%	Shares	Sole	2024-08-13
2024-03-31	$6,631,335	154,038	-6.8%	Shares	Sole	2024-05-14
2023-12-31	$7,612,198	165,267	-54.1%	Shares	Sole	2024-02-14
2023-09-30	$12,292,066	359,838	+18.8%	Shares	Sole	2023-11-13
2023-03-31	$10,843,654	302,980	+867.0%	Shares	Sole	2023-05-11
2022-06-30	$953,119	31,332	+164.0%	Shares	Sole	2022-08-22
2021-09-30	$181,312	11,866	-40.3%	Shares	Sole	2021-11-15
2020-06-30	$249,395	19,888	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.